Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:P01009 SERPINA1

Class:IdReferenceGeneProduct:49238
_chainChangeLogsignal peptide:1-24 added on Fri February 6 2015;chain:25-418 added on Fri February 6 2015;peptide:375-418 added on Fri February 6 2015
_displayNameUniProt:P01009 SERPINA1
_timestamp2026-02-20 21:36:36
chainsignal peptide:1-24
chain:25-418
peptide:375-418
checksum7016555F273B7F16
commentFUNCTION Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.FUNCTION Reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase (HLE).SUBUNIT Interacts with CELA2A (PubMed:31358993). Interacts with ERGIC3 and LMAN1/ERGIC53 (PubMed:31142615). Interacts with PRSS1/trypsin (PubMed:11057674). Interacts with PRSS1/Trypsin (PubMed:11057674). The variants S and Z interact with CANX and PDIA3 (PubMed:23826168).INTERACTION The S and Z allele are not secreted effectively and accumulate intracellularly in the endoplasmic reticulum.SUBCELLULAR LOCATION Ubiquitous. Expressed in leukocytes and plasma.DOMAIN The reactive center loop (RCL) extends out from the body of the protein and directs binding to the target protease. The protease cleaves the serpin at the reactive site within the RCL, establishing a covalent linkage between the carboxyl group of the serpin reactive site and the serine hydroxyl of the protease. The resulting inactive serpin-protease complex is highly stable.PTM N-glycosylated. Differential glycosylation produces a number of isoforms. N-linked glycan at Asn-107 is alternatively di-antennary, tri-antennary or tetra-antennary. The glycan at Asn-70 is di-antennary with trace amounts of tri-antennary. Glycan at Asn-271 is exclusively di-antennary. Structure of glycans at Asn-70 and Asn-271 is Hex5HexNAc4. The structure of the antennae is Neu5Ac(alpha1-6)Gal(beta1-4)GlcNAc attached to the core structure Man(alpha1-6)[Man(alpha1-3)]Man(beta1-4)GlcNAc(beta1-4)GlcNAc. Some antennae are fucosylated, which forms a Lewis-X determinant.PTM Proteolytic processing may yield the truncated form that ranges from Asp-30 to Lys-418.PTM (Microbial infection) Proteolytically processed by Staphylococcus aureus seryl, cysteinyl, and metallo-proteases.POLYMORPHISM The sequence shown is that of the M1V allele which is the most common form of PI (44 to 49%). Other frequent alleles are: M1A 20 to 23%; M2 10 to 11%; M3 14 to 19%.DISEASE The disease is caused by variants affecting the gene represented in this entry.MISCELLANEOUS The aberrant form is found in the plasma of chronic smokers, and persists after smoking is ceased. It can still be found ten years after smoking has ceased.MISCELLANEOUS May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.SIMILARITY Belongs to the serpin family.SEQUENCE CAUTION Extended N-terminus.SEQUENCE CAUTION Extended N-terminus.ONLINE INFORMATION Alpha-1 antitrypsin entry
descriptionrecommendedName: fullName evidence="52"Alpha-1-antitrypsin alternativeName: Alpha-1 protease inhibitor alternativeName: Alpha-1-antiproteinase alternativeName: Serpin A1 component recommendedName: Short peptide from AAT shortName: SPAAT /component
geneNameSERPINA1
AAT
PI
PRO0684
PRO2209
identifierP01009
isSequenceChangedFALSE
keyword3D-structure
Acute phase
Alternative splicing
Blood coagulation
Direct protein sequencing
Endoplasmic reticulum
Extracellular matrix
Glycoprotein
Hemostasis
Phosphoprotein
Protease inhibitor
Proteomics identification
Reference proteome
Secreted
Serine protease inhibitor
Signal
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9983091] Weiser, Joel, 2026-02-20
nameSERPINA1
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:9003356] ENSEMBL:ENSG00000197249 SERPINA1 [Homo sapiens]
secondaryIdentifierA1AT_HUMAN
A6PX14
B2RDQ8
Q0PVP5
Q13672
Q53XB8
Q5U0M1
Q7M4R2
Q86U18
Q86U19
Q96BF9
Q96ES1
Q9P1P0
Q9UCE6
Q9UCM3
sequenceLength418
species[Species:48887] Homo sapiens
(isoformParent)[ReferenceIsoform:217471] UniProt:P01009-2 SERPINA1 [Homo sapiens]
[ReferenceIsoform:217472] UniProt:P01009-3 SERPINA1 [Homo sapiens]
[ReferenceIsoform:402237] UniProt:P01009-1 SERPINA1 [Homo sapiens]
(referenceEntity)[EntityWithAccessionedSequence:141755] SERPINA1 [platelet alpha granule lumen] [Homo sapiens]
[EntityWithAccessionedSequence:141757] SERPINA1 [extracellular region] [Homo sapiens]
[EntityWithAccessionedSequence:5689435] (Glc)3(GlcNAc)2(Man)9-SERPINA1 [endoplasmic reticulum lumen] [Homo sapiens]
[EntityWithAccessionedSequence:5689731] (Glc)3(GlcNAc)2(Man)9-SERPINA1 [COPII-coated ER to Golgi transport vesicle] [Homo sapiens]
[EntityWithAccessionedSequence:5689734] (Glc)3(GlcNAc)2(Man)9-SERPINA1 [endoplasmic reticulum-Golgi intermediate compartment membrane] [Homo sapiens]
[EntityWithAccessionedSequence:6804783] SERPINA1 [ficolin-1-rich granule lumen] [Homo sapiens]
[EntityWithAccessionedSequence:8956709] SERPINA1 [endoplasmic reticulum lumen] [Homo sapiens]
[EntityWithAccessionedSequence:8957062] p-SERPINA1 [endoplasmic reticulum lumen] [Homo sapiens]
(referenceSequence)[GroupModifiedResidue:5689434] N4-(N-acetylamino)glucosyl-L-asparagine (N-{alpha-Glc-(1->2)-alpha-Glc-(1->3)-alpha-Glc-(1->3)-alpha-Man-(1->2)-alpha-Man-(1->2)-alpha-Man-(1->3)-(alpha-Man-(1->2)-alpha-Man-(1->3)-(alpha-Man-(1->2)-alpha-Man-(1->6))-alpha-Man-(1->6))-beta-Man-(1->4)-beta-GlcNAc-(1->4)-beta-GlcNAc}-L-Asn residue (ChEBI:59084)) at unknown position
[ModifiedResidue:8957052] phosphorylated residue at unknown position
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:P01009 SERPINA1 (49238)